| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,226 |
7,249 |
$493K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,393 |
3,217 |
$315K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,350 |
3,815 |
$163K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,010 |
1,466 |
$132K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,512 |
1,197 |
$100K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,208 |
818 |
$88K |
| D1206 |
Topical application of fluoride varnish |
4,859 |
4,790 |
$79K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,694 |
2,025 |
$77K |
| D0190 |
|
4,915 |
4,854 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,583 |
1,893 |
$46K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,148 |
2,981 |
$39K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
659 |
572 |
$38K |
| 92551 |
|
4,466 |
3,189 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,254 |
3,051 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,384 |
2,635 |
$20K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
524 |
477 |
$18K |
| 96127 |
|
3,719 |
2,634 |
$17K |
| 96160 |
|
2,988 |
2,152 |
$13K |
| 99401 |
|
512 |
391 |
$13K |
| 99177 |
|
4,438 |
3,149 |
$11K |
| 81002 |
|
4,743 |
3,347 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
546 |
442 |
$10K |
| 87807 |
|
976 |
753 |
$9K |
| 3008F |
|
591 |
539 |
$5K |
| 85018 |
|
1,546 |
579 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
77 |
44 |
$1K |
| 0071A |
|
53 |
28 |
$1K |
| 83655 |
|
122 |
100 |
$1K |
| 0072A |
|
22 |
13 |
$649.96 |
| 99423 |
|
21 |
21 |
$557.55 |
| 96161 |
|
268 |
226 |
$387.38 |
| 99422 |
|
21 |
19 |
$352.38 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34 |
15 |
$175.80 |
| 81025 |
|
36 |
29 |
$175.68 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
422 |
337 |
$135.69 |
| 99173 |
|
118 |
110 |
$115.80 |
| 36415 |
Collection of venous blood by venipuncture |
63 |
58 |
$113.10 |
| 90686 |
|
1,400 |
1,062 |
$87.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
23 |
15 |
$30.69 |
| 90674 |
|
54 |
50 |
$22.70 |
| 36416 |
|
1,255 |
1,035 |
$3.66 |
| 90670 |
|
625 |
549 |
$0.00 |
| 90648 |
|
182 |
172 |
$0.00 |
| 90633 |
|
217 |
169 |
$0.00 |
| 90658 |
|
294 |
206 |
$0.00 |
| 90734 |
|
160 |
108 |
$0.00 |
| 90672 |
|
233 |
165 |
$0.00 |
| 90715 |
|
17 |
15 |
$0.00 |
| 90681 |
|
12 |
12 |
$0.00 |
| 90461 |
|
47 |
43 |
$0.00 |
| 90707 |
|
33 |
24 |
$0.00 |
| 90651 |
|
569 |
402 |
$0.00 |
| 90698 |
|
232 |
188 |
$0.00 |
| 90688 |
|
377 |
330 |
$0.00 |
| 90723 |
|
151 |
142 |
$0.00 |
| 90744 |
|
17 |
12 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
61 |
60 |
$0.00 |
| 90716 |
|
29 |
24 |
$0.00 |
| 91307 |
|
76 |
37 |
$0.00 |
| 90657 |
|
18 |
14 |
$0.00 |
| 90620 |
|
20 |
15 |
$0.00 |